Cargando…

Safety and improvement of movement function after stroke with atomoxetine: A pilot randomized trial

Background: Intensive, task-oriented motor training has been associated with neuroplastic reorganization and improved upper extremity movement function after stroke. However, to optimize such training for people with moderate-to-severe movement impairment, pharmacological modulation of neuroplastici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Andrea, Carrico, Cheryl, Powell, Elizabeth, Westgate, Philip M., Nichols, Laurie, Fleischer, Anne, Sawaki, Lumy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302031/ https://www.ncbi.nlm.nih.gov/pubmed/27858723 http://dx.doi.org/10.3233/RNN-160673

Ejemplares similares

Chronicity of Stroke Does Not Affect Outcomes of Somatosensory Stimulation Paired With Task-Oriented Motor Training: A Secondary Analysis of a Randomized Controlled Trial
por: Carrico, Cheryl, et al.
Publicado: (2019)

The effect of transcutaneous spinal direct current stimulation on corticospinal excitability in chronic incomplete spinal cord injury
por: Powell, Elizabeth Salmon, et al.
Publicado: (2018)

Absence of Motor-Evoked Potentials Does Not Predict Poor Recovery in Patients With Severe-Moderate Stroke: An Exploratory Analysis
por: Powell, Elizabeth S., et al.
Publicado: (2019)

Effects of dynamic body weight support on functional independence measures in acute ischemic stroke: a retrospective cohort study
por: Huber, Justin, et al.
Publicado: (2023)

Impact of motor therapy with dynamic body-weight support on Functional Independence Measures in traumatic brain injury: An exploratory study
por: Anggelis, Emily, et al.
Publicado: (2019)

Dynamic body-weight support to boost rehabilitation outcomes in patients with non-traumatic spinal cord injury: an observational study
por: Huber, Justin P., et al.
Publicado: (2020)

The effect of atomoxetine on random and directed exploration in humans
por: Warren, Christopher M., et al.
Publicado: (2017)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
por: Carlson, Gabrielle A, et al.
Publicado: (2007)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2015)

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012)

Treatment of Children and Adolescents with Epilepsy with Atomoxetine
por: Park, Kee Jeong, et al.
Publicado: (2020)

Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial
por: Tajdini, Masih, et al.
Publicado: (2021)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012)

Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015)

Atomoxetine in abstinent cocaine users: Sex differences
por: DeVito, Elise E., et al.
Publicado: (2017)

Functional recovery outcomes following acute stroke is associated with abundance of gut microbiota related to inflammation, butyrate and secondary bile acid
por: Hammond, Tyler C., et al.
Publicado: (2022)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
por: Fenderson, Joshua L., et al.
Publicado: (2013)

The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite
por: TODOR, IOANA, et al.
Publicado: (2015)

Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease
por: Borchert, Robin J, et al.
Publicado: (2016)

Atomoxetine restores the response inhibition network in Parkinson’s disease
por: Rae, Charlotte L., et al.
Publicado: (2016)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Publicado: (2020)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
por: Byun, Jung‐Ick, et al.
Publicado: (2019)

The effect of atomoxetine on cognitive function in patients with multiple sclerosis
por: Mohammadian Nejad, Ehsan, et al.
Publicado: (2023)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

Pilot Test of Dosage Effects in HEXORR II for Robotic Hand Movement Therapy in Individuals With Chronic Stroke
por: Chen, Ji, et al.
Publicado: (2021)

Atomoxetine modulates the relationship between perceptual abilities and response bias
por: Guedj, Carole, et al.
Publicado: (2019)

Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
por: Borchert, Robin J, et al.
Publicado: (2019)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
por: Suzuki, Shiho, et al.
Publicado: (2020)

Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
por: Finsterer, Josef, et al.
Publicado: (2020)

Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
por: Cassar, Fabrizia, et al.
Publicado: (2021)

Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
por: Silverstone, Peter H, et al.
Publicado: (2012)

Effect of Atomoxetine on the Cognitive Functions in Treatment of Attention Deficit Hyperactivity Disorder in Children with Congenital Hypothyroidism: A Pilot Study
por: Yang, Rongwang, et al.
Publicado: (2015)

Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea
por: Chen, Tien-Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_negspvqk5ih416u9fgsu6kum9u